BUZZ-Insys Therapeutics Inc: Epilepsy drug gets orphan status

Wed Jun 25, 2014 9:21am EDT

** Specialty pharmaceutical company's shares up 5 pct at $30.45 after U.S. FDA granted orphan drug designation to its experimental epilepsy drug

** The company plans to file for an application to start human trials of the drug in the second half of 2014